Governed preclinical and portfolio decision support.
PredX
Governed pharmaceutical decisioning for teams that need trusted evaluation, not black-box theater.
PredX is the Tillar Technologies product line for governed pharmaceutical and preclinical decision work. It supports evaluation, prioritization, and evidence review where the quality of the decision matters more than speed alone.
PredX gives teams a disciplined way to reason about candidates, portfolios, and conflicting evidence before high-cost scientific decisions move forward.
Product View
Governed evaluation for pharmaceutical decisions.
PredX gives pharmaceutical teams a governed decision environment for evidence review, portfolio triage, and high-consequence prioritization.
Evidence review, prioritization, and higher-trust decision workflows.
Teams that need stronger evaluation discipline before committing capital, time, or attention.
What It Sells
- Governed evidence review for pharmaceutical work
- Higher-trust portfolio triage and prioritization
- Decision support where credibility and traceability matter
- A disciplined workflow for high-consequence scientific review
What Makes It Different
- Decision quality leads the product, not generic technology excitement
- Claims stay bounded, defensible, and buyer-relevant
- Governance is part of the workflow, not after-the-fact reporting
- Evidence review connects directly to portfolio and capital decisions
PredX
Built for teams that need stronger judgment around scientific and portfolio decisions.
PredX is the right fit when the buyer needs governed decision support around pharmaceutical evaluation, especially where weak evidence handling creates cost, delay, or misallocation.
Best Entry Points
Start where governed evaluation creates immediate business value.
Use Cases
- Preclinical review and prioritization
- Asset kill, rescue, or ranking discussions
- Governed review of conflicting evidence
Buyers
- Portfolio strategy leaders
- Translational and preclinical decision owners
- Operators responsible for high-cost judgment calls
Commercial Signal
PredX is governed pharmaceutical decisioning and evaluation for teams that need stronger judgment before advancing costly scientific work.
Demo Path
Review candidate outcomes before high-cost commitments.
The PredX demo uses visible verdict states and receipt-style summaries to show how a candidate can advance, pause, or stop.